We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
If the SP rises to 56p in a year, I buying these shares for my isa account in April 😁
This seems to be a good company where directors are buying into their own company.
Always a good sign.
.....well, this makes happy reading!
https://markets.investorschronicle.co.uk/data/equities/tearsheet/forecasts?s=ABDX:LSE#:~:text=Share%20price%20forecast,the%20last%20price%20of%2010.00.
pie in the sky?
I think the pull back is nearly over post TU spike.
There is currently a strong BID with SING bidding for 250K feels like they are filling a big order.
Only a small amount £1K available sub 9.5p.
Mostly buys so far today,will share price move up ?
Happy Easter Muck165! Still seeking those golden eggs I see. Appears to be a very likely trigger to buy more shares to me. I'm comforted that they cost roughly the same price as now- give or take a penny. Looking good.
It’s also noteworthy that Yates/Hand bought c1m shares between them (being the only significant Director buys, and the only time Yates has bought since listing) for c£75k between during a 9 day spree starting just 3 days after Devyn converted to an LLC on 11/9/22.
Could easily just be coincidence I accept!
https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=DEVYN%20L220005084000&aggregateId=flal-l22000508400-4eb7a6cf-05f4-4291-9c72-703b60fb5229&searchTerm=Devyn%20llc&listNameOrder=DEVYN%20L220005084000
https://www.lse.co.uk/DirectorsDeals.html?shareprice=ABDX&share=Abingdon-Healt
Oh and lest we forget, new tax year starts 6/4 and with it all the new ISA allowances that will hit the market. Great time to be in this stock IMO.
Interesting…thanks.
Devyn converted from Devyn Inc to Devyn LLC wef Sept 22, so it would appear we’ve been working with them ever since that conversion. Does make you wonder if an equity partnership in a Devyn subsid (FOFH) was always the plan.
April looks potentially good news heavy.
My bet is;
1) for a Loop/ABDX announcement re UKCA early next week.
2) an addition to the Boots own brand suite very soon - thyroid I’m guessing.
3) fair chance of Upfront UKCA and/or successful new funding round for them
And as a more off the wall prediction, I think we may see something more concrete about our relationship with Senzo, perhaps that the FOFH tests are based on its ALF platform, and I also have suspicions that something might be going on between ABDX and a company called Drummond Scientific in the States. Whether or not that turns out true, it is a simple fact that our involvement in US based entities, and reactions ABDX is getting from US based people, is increasing. Worth noting again that Yates said only in January that the US market is important and that 50% of our customers hail from there - that means 14/15 of our current projects are for US customers.
Absolutely amazing research Muck165. Fantastic that you've spotted an opportunity should there be another imminent spike due to news that Septiloop is registered in the UK and must therefore have UKCA, as you say. I will be ready for the next drop you characteristically see before good news these days, and will be adding again. This is all too good to miss IMO
Interesting post on Linkedin from Chris Yates re :Yannick Namia
Been fantastic working with you over the past 18
months. Looking forward to building on our partnership to provide #lateralflow #STD tests to the #selftest and #pointofcare market and leveraging Abingdon Health plc’s growing sales and distribution platform. #rapidtesting #innovation
Leading the Charge in At-Home Diagnostic Solutions
I am thrilled to share with you all an exciting new chapter — I have stepped into a new venture, in partnership with Abingdon Health plc and his CEO Chris Yates to develop Find Out From Home, a pioneering venture in the at-home diagnostic space.
In an era where the rates of STDs and STIs are climbing across all age groups, our mission couldn't be more critical. Find Out From Home is at the forefront of introducing the next wave of at-home diagnostic solutions, dedicated to combating these rising rates head-on.
Our promise to our users is threefold: anonymity, rapid results, and affordability. With tests that deliver results in just 10 to 20 minutes, we are setting a new standard for convenience without compromising accuracy or privacy.
This innovation is not just about offering a product; it's about offering peace of mind, empowerment, and the chance for individuals to take control of their sexual health discreetly and efficiently.
By making STD and STI testing accessible and stress-free, we are taking significant steps towards halting the spread of infections nationwide and paving the way for a healthier future.
https://www.linkedin.com/feed/update/urn:li:activity:7179445507600064512/
Pleasure Apre. Next one I’m looking out for is Upfront MRHA registration, which they are strongly signposting as being imminent (note, this may well be registered under Pockit DX when it comes).
I don’t really know how these things work, but Loop have been waiting for UKCA for a while and would, I’d have thought, been setting up sales for when it arrived. If that’s the case, it might better explain Yates decision to waive fees for equity in FOFH. Would seem a lot less strange if he knew he had a nice Loop manufacturing order waiting in the wings.
One other thing - incorrect Sepsis antibiotic treatment isn’t helping the massive global AMR problem, so that’s another value add for Septiloop.
Muck, you are on a real roll at the moment . . . a mine of information. Thank you for sharing all the research and for the reasoned commentary.
You should be ABDX's PR man . . .
Final one from me, but just to note that after checking it’s clear that as part of the MRHA registration process a company MUST provide a copy of its conformity assessment. So there is no doubt that Septiloop, having now been registered, must have UKCA and can now be sold in the U.K.
Also worth remembering that the Health Ombudsman published a damning report on the state of U.K. Sepsis care in the Autumn, nicely titled “TIME TO ACT Severe Sepsis: Rapid diagnosis and treatment saves lives”, and in that report identified that NHS cost savings of £196m p/a could be achieved if that were to happen.
A great time to be launching this 3x more sensitive and 10x faster diagnostic into the U.K. market, and I think a great opportunity to get in or add here if you can before formal announcements are made.
https://www.ombudsman.org.uk/sites/default/files/Time_to_act_report.pdf
Really excited by this - to give a flavour of the market you need only look at this from the U.K. Sepsis Trust
“Every 3 seconds, someone in the world dies of sepsis. In the UK alone, 245,000 people are affected by sepsis with at least 48,000 people losing their lives in sepsis-related illnesses every year. This is more than breast, bowel and prostate cancer combined. Globally, sepsis claims 11 million lives a year. Yet, for many patients, with early diagnosis it is easily treatable.”
https://sepsistrust.org/about/
On 16/3/23 Salignostics/Salistick became registered with the MRHA, leading ABDX to say in a 31/3 RNS - “ We were pleased to see Salistick™ achieve Medicines and Healthcare products Regulatory Agency (MHRA) approval in March 2023 and will therefore be available for sale in the United Kingdom and we remain on target for an exclusive launch of Salistick™ on the Abingdon Simply Test™ website and on Amazon before the end of this financial year.”
I am excited to see, therefore that on 14/3/24 Loop Diagnostics/Septiloop achieved MRHA registration, which I am VERY reasonably assuming means that Septiloop, like Salistick, has now achieved UKCA and can be sold in the U.K. market.
Neither Loop or ABDX have said anything about this yet, but I’m sure it won’t be long and I would imagine it will give a very nice little shot in the arm of the SP! Remember, Septiloop is one of the products that ABDX has taken through tech transfer, scale up, and into manufacturing.
https://pard.mhra.gov.uk/manufacturer-details/110414 ((Salistick registration)
https://pard.mhra.gov.uk/manufacturer-details/117995 (Septiloop registration)
https://www.youtube.com/watch?v=4Z32joS9aD4 (See slide at 11 mins in)
Further on this, but a week or so ago Upfront presented at the Cambridge Enterprise Venture Partners Investor showcase, and this would seem to be their full pitch presentation (which is far more detailed than anything I’ve seen before).
It makes for interesting reading!
https://www.enterprise.cam.ac.uk/wp-content/uploads/2024/03/240305-Upfront-LVOne-full-deck-1.pdf
....so true. Great thoughts!
For those interested, a bit of reading from the European Centre for Disease Control from earlier this month, highlighting the increase in STI’s (including Syphillis, one our new tests), and commenting about how early testing is crucial. Just seems to me that the “embarrassment” factor might stop many from going to the docs, another reason why discrete at home LFT testing might benefit.
https://www.ecdc.europa.eu/en/news-events/sti-cases-rise-across-europe#:~:text=In%202022%2C%20the%20number%20of,and%20chlamydia%20cases%20by%2016%25.
We love you Muck165, that excitement just keeps on growing. When those interest rates in the UK finally drop (hopefully this year), you just watch this investment take off. Really believe my" Luks in" this time!
If these new tests are built on the Senzo ALF platform, then that might well explain Yates decision to invest because everything I’ve read suggests that historically LFT’s have struggled in the STI market because achievable sensitivity was too low and that is precisely what the ALF platform addresses.
I enjoy it Metatron - gives an old fogey something to do!
As I say, I do have a suspicion that these new tests may be built using the Senzo amplification platform. I’ve already given some reasons why in earlier posts, but another is that this lady regularly began reacting to ABDX posts from at least 4-5 months ago, and she very quickly reacted to Abingdon’s LinkedIn post about our new relationship/investment by commenting; “ Congratulations, Chris and team. Desperately needed tests for individual health and public health.”
Why is that relevant - well she is an IVD consultant who has been advising a company called Bioadvance Ventures since 2022, a VC company that counts Senzo as one of it’s investee companies.
https://www.linkedin.com/in/cfinkmdte/
https://www.bioadvance.com/portfolio/
Very interesting read today Muck.. thanks for the sleuthing you first class sleuther
By trawling through various US state registries I’ve now found Find Out From Home LLC, registered in Delaware on 9/8/23.
https://icis.corp.delaware.gov/Ecorp/EntitySearch/NameSearch.aspx